Analyst Allen Lutz of Bank of America Securities maintained a Hold rating on Omnicell (OMCL – Research Report), retaining the price target of $46.00. Allen Lutz has given his Hold rating due to ...

Advocacy group alleges EU user data unlawfully sent to China Noyb's first complaint against Chinese firms China says it does not breach local laws, protects data STOCKHOLM/BRUSSELS, Jan 17 ...

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the fourth quarter ...

When you multiply by 1 the answer stays the same. 21 × 1 = 21 When you multiply by 10, move all the digits one place to the left, putting a zero in the empty space. 21 × 10 = 210 When you ...

In the second quarter of 2024, Omnicell delivered a strong performance that exceeded analyst expectations. The company reported revenue, EBITDA, and earnings per share (EPS) that surpassed projections ...

Get prepared with the key expectations. Enovis, Omnicell and Phreesia have been highlighted in this Industry Outlook article. Zacks Medical Info Systems industry stocks like Enovis, Omnicell and ...

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...